IQVIA Holdings Inc (IQV)
NYSE · Healthcare · Diagnostics & Research
IQVIA Holdings Inc is a Healthcare company with a market capitalization of $31.90B and a trailing P/E ratio of 23.7.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | May 5, 2026 | $2.90 | $2.82 | +2.8% |
| Q4 2025 | February 5, 2026 | $3.42 | $3.40 | +0.6% |
| Q3 2025 | October 28, 2025 | $3.00 | $2.98 | +0.7% |
| Q2 2025 | July 22, 2025 | $1.54 | $1.73 | -11.0% |
| Q1 2025 | May 6, 2025 | $2.70 | $2.63 | +2.7% |
| Q4 2024 | February 6, 2025 | $3.12 | $3.11 | +0.3% |
Other Diagnostics & Research Stocks
Frequently Asked Questions
What is IQVIA Holdings Inc's market cap?
As of June 29, 2026, IQVIA Holdings Inc (IQV) has a market capitalization of $31.90B.
What is IQVIA Holdings Inc's P/E ratio?
IQVIA Holdings Inc trades at a trailing price-to-earnings (P/E) ratio of 23.7. Its forward P/E is 15.0.
Does IQVIA Holdings Inc pay a dividend?
IQVIA Holdings Inc does not currently pay a dividend.
What sector is IQV in?
IQVIA Holdings Inc is in the Healthcare sector, specifically the Diagnostics & Research industry.
What was IQVIA Holdings Inc's revenue?
In its latest reported fiscal year (ending December 31, 2025), IQVIA Holdings Inc reported revenue of $16.31B and net income of $1.36B.
Ask your own questions about IQV
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.